1. Role: Department Chairperson. Scope: Department. Date: 2012.
R. Chris Rathbun, Pharm.D., BCPS, AQ-ID
Prof & Chair
Pharmacy Clinical & Admin Sci
Phone (405) 271-6878 x47254
Fax (405) 271-6430
Office CPB 211
Email chris-rathbun@ouhsc.edu
Summary
Research interests are centered in the area of HIV infection and include optimization of antiretroviral therapy, evaluation of novel antiretroviral agents and treatment strategies, medication adherence with antiretroviral regimens, and pharmacokinetic/pharmacodynamics drug interactions among antiretrovirals.
Research
Infectious diseases.
Publications & Presentations
- 11. Phan Y L, Ripley T L, Herring H, Harrison D, Rathbun C. Impact of dabigatran and rivaroxaban on the proportion of nonvalvular atrial fibrillation (NVAF) patients prescribed an anticoagulant for the prevention of stroke and systemic embolism, 2009 - 2012. Journal of Pharmacy and Clinical Sciences. 2016; 9 : 1-8
12. Oldham M M, Liedtke M D, Lockhart S M, Rathbun C. The role of dolutegravir in the management of HIV infection. Infection and Drug Resistance/Dove Press. 2015; 8
13. Ripley T L, Adamson P B, Hennebry T A, Van Tuyl J S, Harrison D, Rathbun C. Collaborative Practice Model Between Cardiologists and Clinical Pharmacists for Management of Patients With Cardiovascular Disease in an Outpatient Clinic. The Annals of pharmacotherapy. 2014; 48 : 412-419
14. Kleyn T J, Liedtke M D, Harrison D, Lockhart S M, Salvaggio M R, Ripley T L, Rathbun C. Incidence of Transmitted Antiretroviral Drug Resistance in Treatment-Naïve HIV-1 Infected Persons in a Large South Central United States Clinic. Annals of Pharmacotherapy. 2014; 48 : 470-475
15. Liedtke M D, Tomlin C R, Oldham M M, Lockhart S M, Rathbun C. Long-term efficacy of raltegravir in the management of HIV infection. Infection and Drug Resistance/Dove Press. 2014; 7 : 73-84
Grants
- 11. Clinical Pharmacy Services. HHS. Start Date: 2017. End Date: 2017.
12. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
13. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
14. HIV Adherence Services. State Agency. Start Date: 2016. End Date: 2017.
15. Clinical Pharmacy Services. HHS. Start Date: 2016. End Date: 2016.
Awards and Honors
- 1. SWOSU/OU Preceptor's Conference. Outstanding Preceptor. Date: 2021.
2. American College of Clinical Pharmacy. Fellow. Date: 2015.
3. OU Health Sciences Center. Regent's Award for Superior Teaching. Date: 2004.
4. OU College of Pharmacy Alumni Association. Teaching Excellence Award. Date: 1998.
5. Phi Lambda Sigma Leadership Society (Alpha-Epsilon chapter)Honorary Faculty Award for Outstanding Leadership and Service. Date: 1997.
Education
- 1. Degree: BS. University of Minnesota, Duluth. Date: 2005.
2. Degree: Infectious Diseases Fellowship. University of Texas at Austin. Date: 1991.
3. Degree: PharmD. University of Minnesota, Mpls-St. Paul. Date: 1989.
Administrative Assignments
2. Role: Department Vice-Chair. Scope: Department. Date: 2011.